Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 4, 1996, Pages 523-532

  O'Brien, Kevin D ^a   Reichenbach, Dennis D ^b   Marcovina, Santica M ^b   Kuusisto, Johanna ^a,c   Alpers, Charles E ^b   Otto, Catherine M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

inflammation foam cells; lipids; macrophages

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E;

AORTA VALVE STENOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DEGENERATIVE DISEASE; DRUG ACCUMULATION; FOAM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE FUNCTION; PRIORITY JOURNAL;

EID: 0029872345     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.4.523     Document Type: Article

References (64)

1. Monckeberg JG. Der normale histologische bau und die sklerose der aortenklappen. Virchows Arch Pathol Anat. 1904;176:472-514.
2. Christian HA. Aortic stenosis with calcification of the cusps. JAMA. 1931;97:158-161.
3. Sohval AR, Gross L. Calcine sclerosis of the aortic valve (Monckeberg type). Arch Pathol. 1936;22:477-494.
4. Clawson BJ, Noble JF, Lufkin NH. The calcified nodular deformity of the aortic valve. Am Heart J. 1938;15:58-76.
5. Hultgren HN. Calcific disease of the aortic valve. Arch Pathol. 1948;45:694-706.
6. Sell S, Scully RE. Aging changes in the aortic and mitral valves: histologic and histochemical studies, with observations on the pathogenesis of calcific aortic stenosis and calcification of the mitral annulus. Am J Pathol. 1965;46:345-355.
7. Marigolds HMO, Ziellessen FO, Barnes AR. Calcareous aortic valvular disease. Am Heart J. 1931;6:349-374.
8. Ashworth CT. Atherosclerotic valvular disease of the heart. Arch Pathol. 1946;42:285-298.
9. Walton KW, Williamson N, Johnson AG. The pathogenesis of atherosclerosis of the mitral and aortic valves. J Pathol. 1970;101:205-220.
10. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histologic and immunohistochemical studies. Circulation. 1994;90:844-853.
11. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
12. Olsson M, Rosenqvist M, Nilsson J. Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol. 1994;24:1664-1671.
13. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23:1162-1170.
14. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli CM, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995;92:2163-2168.
15. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993;143:1003-1008.
16. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
17. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993;92:2814-2820.
18. Shanahan CM, Cary NRN, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-2402.
19. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest. 1994;94:1597-1604.
20. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809.
21. Lawn RM. Lipoprotein(a) in heart disease. Sci Am. 1992;266:54-60.
22. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, Utermann G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990;322:1494-1499.
23. Tato F, Keller C, Schuster H, Spengel F, Wolfram G, Zollner N. Relation of lipoprotein(a) to coronary heart disease and duplex sonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia. Atherosclerosis. 1993;101:69-77.
24. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb. 1993;13:1558-1566.
25. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
26. O'Brien KD, Deeb SS, Ferguson M, McDonald TO, Allen MD, Alpers CE, Chait A. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol. 1994;144:538-548.
27. Salomon RN, Underwood R, Doyle MV, Wang A, Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicated selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci U S A. 1992;89:2814-2818.
28. Rosenfeld ME, Butler S, Ord VA, Lipton BA, Dyer CA, Curtiss LK, Palinski W, Witztum JL. Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb. 1993;13:1382-1389.
29. Bacchi CE, Marsh CL, Perkins JD, Carithers RL Jr, McVicar JP, Hudkins KL, Benjamin CD, Harlan JM, Lobb R, Alpers CE. Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol. 1993;142:579-591.
30. Skalli O, Ropraz P, Trzecia K, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against gamma-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
31. Sugiyama N, Marcovina S, Gown AM, Seftel H, Joffe B, Chait A. Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. Am J Pathol. 1992;141:99-106.
32. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41:246-255.
33. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
34. Jurgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb. 1993;13:1689-1699.
35. Kaesberg B, Harrach B, Dieplinger H. Robenek H. In situ immunolocalization of lipoproteins in human arteriosclerotic tissue. Arterioscler Thromb. 1993;13:133-146.
36. Pomerance A, Darby AJ, Hodkinson HM. Valvular calcification in the elderly: possible pathogenic factors. J Gerontol. 1978;33:672-675.
37. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. Development and progression of aortic valve stenosis: atherosclerosis risk factors - a causal relationship? a clinical morphologic study. Clin Cardiol. 1991;14:995-999.
38. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987;59:998-999.
39. Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis. 1984;37:407-415.
40. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD. A definition of the intima of human arteries and of its atherosclerosis-prone regions: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1992;12:120-134.
41. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
42. Gushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87:5134-5138.
43. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254-257.
44. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
45. Witztum JL. Role of oxidized low density lipoprotein in atherogenesis. Br Heart J. 1993;69:S12-S18.
46. Salisbury BG, Falcone DJ, Minick CR. Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages. Am J Pathol. 1985;120:6-11.
47. Hurt E, Camejo G. Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. Atherosclerosis. 1987;67:115-126.
48. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis. 1989;9:1-20.
49. Vijayagopal P, Srinivasan SR, Xu JH, Dalferes ER Jr, Radhakrishnamurthy B, Berenson GS. Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions. J Clin Invest. 1993;91:1011-1018.
50. O'Brien KD, Alpers CE, Ferguson M, Wight T, Chait A. Colocalization of apolipoprotein E and biglycan in human atherosclerotic plaques. Circulation. 1993;90:1-403. Abstract.
51. Martin BJ, Thomas S, Greenhill NS, Ryan PA, Davis PF, Stehbens WE. Isolation and purification of extracellular matrix vesicles from blood vessels. Prep Biochem. 1992;22:87-103.
52. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc. 1976;35:156-162.
53. Kim KM, Valigorsky JM, Mergner WJ, Jones RT, Pendergrass RF, Trump BF. Aging changes in the human aortic valve in relation to dystrophic calcification. Hum Pathol. 1976;7:47-60.
54. Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci USA. 1981;78:7545-7549.
55. Basu SK, Goldstein JL, Brown MS. Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. Science. 1983;219:871-873.
56. Basu SK, Ho YK, Brown MS, Bilheimer DW, Anderson RGW, Goldstein JL. Biochemical and genetic studies of the apoE secreted by mouse macrophages and human monocytes. J Biol Chem. 1982;257:9788-9795.
57. Mazzone T, Reardon C. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. J Lipid Res. 1994;35:1345-1353.
58. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 1994;144:962-974.
59. Westergren Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest. 1993;92:632-637.
60. Thubrikar MJ, Nolan SP, Aouad J, Deck JD. Stress sharing between the sinus and leaflets of canine aortic valve. Ann Thorac Surg. 1986;42:434-440.
61. Thubrikar MJ, Aouad J, Nolan SP. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am J Cardiol. 1986;58:304-308.
62. Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S, Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol. 1993;71:322-327.
63. Isner JM, Chokshi SK, DeFranco A, Braimen J, Slovenkai GA. Contrasting histoarchitecture of calcified leaflets from stenotic bicuspid versus stenotic tricuspid aortic valves. J Am Coll Cardiol. 1990;15:1104-1108.
64. Maher ER, Pazianas M, Curtis JR. Calcific aortic stenosis: a complication of chronic uraemia. Nephron. 1987;47:119-122.